Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
Go back to Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System| Johnson & Johnson (NYSE: JNJ) | Delayed: 244.88 +3.88 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $241.00 | 52 Week High | $126.07 | |||
| Open | $241.27 | 52 Week Low | $94.28 | |||
| Day High | $248.19 | P/E | 50.91 | |||
| Day Low | $240.89 | EPS | $4.81 | |||
| Volume | 10,077,662 | |||||
